Download Library

Investors

Download Library

 
Download Library
Date Document Type
  Factor 12 RNAi-based therapeutic as a prophylactic anti-thrombotic therapy
  View Transcript
  EASL 2017 ARCAAT-1001 Presentation
  EASL 2017 ARC520-2001 Presentation
  EASL 2017 ARC521-1001 Poster
  Progress in RNAi-based therapeutics at Arrowhead Pharmaceuticals
  RNAi subcutaneous delivery platform development and ARO-F12
  View Transcript
  AMGEN AND ARROWHEAD PHARMACEUTICALS ANNOUNCE TWO CARDIOVASCULAR COLLABORATIONS
  View Presentation
Page:
1
NextLast
= add file to Briefcase